SCHEMBL6948526

SCHEMBL6948526

N#Cc1c(OCC(F)(F)F)nc(CCOC2CCCCO2)nc1N1CCc2ccccc2CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.36
PIK3CD O00329 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
KDM4E B2RXH2 6/20 0.34
ALDH1A1 P00352 6/20 0.34
HPGD P15428 4/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
GAA P10253 2/20 0.34
LMNA P02545 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
IDH1 O75874 2/20 0.33
CHEK1 O14757 2/20 0.33
HTT P42858 3/20 0.32
NPSR1 Q6W5P4 2/20 0.32
HSD17B10 Q99714 2/20 0.32
MAPK1 P28482 1/20 0.32
HIF1A Q16665 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6953594 0.92 PIK3CD (0.36) KDM4CL3MBTL1PIK3CDKDM4EALDH1A1
SCHEMBL6950944 0.91 KDM4C (0.41) KDM4CL3MBTL1NPC1RAB9AKDM4E
SCHEMBL6948613 0.90 KDM4C (0.40) KDM4CL3MBTL1NPC1RAB9AKDM4E
SCHEMBL6955400 0.81 PIK3CD (0.38) L3MBTL1PIK3CDRAB9AKDM4EALDH1A1
SCHEMBL6950700 0.81 PIK3CD (0.38) L3MBTL1PIK3CDKDM4EALDH1A1HPGD
SCHEMBL6948239 0.78 PIK3CD (0.39) L3MBTL1PIK3CDRAB9AKDM4EALDH1A1
SCHEMBL6945764 0.78 PIK3CD (0.37) L3MBTL1PIK3CDRAB9AKDM4EALDH1A1
SCHEMBL6949294 0.78 KDM4E (0.43) L3MBTL1PIK3CDKDM4EALDH1A1HPGD
SCHEMBL6953035 0.77 KDM4C (0.40) KDM4CL3MBTL1NPC1RAB9AKDM4E
SCHEMBL6957600 0.77 KDM4C (0.39) KDM4CL3MBTL1NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed